Ann: Immutep collaborates with MSD for phase 2b head & neck trial, page-18

I bought into this little fella when it was Prima Biomed a good 10yrs ago, one of those ones that a mate told me about. I held my small package for a long time. Covid turned me into a bit of a swing trader with lockdowns, and I've done well with IMM, mostly with the gold run though.
Mostly the announcements speak a different languge to me but I feel I get the overall gist of it.
Watching this little fella progress, I'm getting a bit of a feeling that it's time to buckle down and hold my position. Maybe trade a smaller fraction now.
I'm sure most of us have been affected by cancer in some way, this was a significant motivator for me.
From my point of view, we are a small aussie company (not to be scoffed at), we have advanced trials, we have collaborations with big pharma. We have an avenue of interest in immunotherapy that is producing results and making the news. We have a global health crisis...
GLAH
Tomorrow looks good